Target Pipelines
In this product category, you will find reports in a tabular format providing you with the most uptodate competitive intelligence information about target-specific R&D pipelines. This low-cost product service provides information about active R&D projects for a given target in the format of Word tables.
Subscribe to
our newsletters!
Showing 1–20 of 30 resultsSorted by latest
-
On demand upon order placementThis competitive intelligence report about IGF-1(R)-Targeted Immunotherapies provides an up-to-date competitor evaluation in the field of product candidates in R&D targeting IGF-1R or its ligand IGF-1.€ 300.00
-
On demand upon order placementThis competitive intelligence report about NaPi2b-Targeted Immunotherapies provides an up-to-date competitor evaluation in the field of product candidates in R&D targeting NaPi2b.€ 200.00
-
On demand upon order placementThis competitive intelligence report about FcRn-Targeted Immunotherapies provides an up-to-date competitor evaluation in the field of product candidates inR&D targeting FcRn.€ 200.00
-
On demand upon order placementThis service reviews the pipeline of immunotherapies against customer-selected targets for drug development in the biopharmaceutical industry.
-
On demand upon order placementThis competitive intelligence report about KLK2-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting KLK2.€ 100.00
-
On demand upon order placementThis competitive intelligence report about Tissue Factor-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting tissue factor.€ 200.00
-
On demand upon order placementThis competitive intelligence report about CD38-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting CD38.€ 300.00
-
On demand upon order placementThis competitive intelligence report about TROP-2-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting TROP-2.€ 300.00
-
On demand upon order placementThis competitive intelligence report about Nectin-4-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting nectin-4.€ 200.00
-
On demand upon order placementThis competitive intelligence report about CCR8-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting CCR8.€ 300.00
-
On demand upon order placementThis competitive intelligence report about EpCAM-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting EpCAM.€ 200.00
-
On demand upon order placementThis competitive intelligence report about B7-H4-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting B7-H4.€ 300.00
-
On demand upon order placementThis competitive intelligence report about Mesothelin-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in R&D targeting mesothelin€ 300.00
-
On demand upon order placementThis competitive intelligence report about c-Met-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in research and development targeting c-Met.€ 300.00
-
On demand upon order placementThis competitive intelligence report about Her3-Targeted Immunotherapies provides a competitor evaluation in the field of product candidates in research and development targeting Her3.€ 300.00
-
August of 2025This competitive intelligence report about DLL3-Targeted Therapy provides a competitor evaluation in the field of product candidates targeting delta-like ligand 3 (DLL3) as of August of 2025.€ 300.00
-
August of 2025This competitive intelligence report about B7-H3 Targeted Therapy provides a competitor evaluation in the field of product candidates targeting B7-H3 (or CD276) as of August of 2025.€ 300.00
-
July of 2025This competitive intelligence report about GPC3 Targeted Therapy provides a competitor evaluation in the field of product candidates targeting glypican-3 (GPC3) as of July of 2025.€ 400.00
-
July of 2025This competitive intelligence report about Fibroblast Activation Protein (FAP) Targeted Therapy provides a competitor evaluation in the field of product candidates targeting Fibroblast Activation Protein (FAP) as of July of...€ 300.00
-
July of 2025This competitive intelligence report Folate Receptor alpha (FRα) Targeted Therapy provides a competitor evaluation in the field of product and product candidates targeting Folate Receptor alpha as of July of...€ 200.00